Gabapentin for muscle spasms
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Muscle Spasms: Efficacy and Applications
Gabapentin for Spasticity in Multiple Sclerosis
Gabapentin has been studied extensively for its effects on spasticity and muscle spasms in patients with multiple sclerosis (MS). In a double-blind, placebo-controlled crossover study, patients with MS who were administered 400 mg of gabapentin three times daily showed significant improvements in spasticity and muscle cramps, as measured by the Ashworth Scale, Visual Faces Scale, and Kurtzke Disability Scale. Another study corroborated these findings, demonstrating that gabapentin significantly reduced spasticity and painful muscle spasms in MS patients, as evidenced by both self-report scales and physician-administered scales.
Gabapentin for Spasticity in Spinal Cord Injury
Gabapentin has also been evaluated for its effectiveness in controlling spasticity in individuals with spinal cord injury (SCI). A study using surface electromyography (EMG) found that while the group results did not reach statistical significance at a dose of 400 mg three times daily, individual cases showed notable improvements in spasticity, particularly at higher doses. Another randomized, double-blind, placebo-controlled crossover study involving SCI patients reported an 11% reduction in spasticity as measured by the Ashworth Scale and a 20% reduction in patient-reported spasticity on the Likert Scale.
Gabapentin for Upper Motor Neuron Syndrome
In patients with upper motor neuron syndrome, gabapentin has shown promise as a treatment for spasticity. A pilot study involving patients with pyramidal-tract lesions demonstrated significant improvements in Ashworth Scale scores and spasm frequency when treated with gabapentin at doses up to 3,600 mg/day. This study highlighted gabapentin's efficacy and safety, with fewer adverse events reported compared to the placebo group.
Gabapentin for Isaacs' Syndrome and Hemifacial Spasm
Gabapentin has also been effective in treating muscle spasms associated with Isaacs' syndrome and hemifacial spasm. In a case study of a patient with Isaacs' syndrome, gabapentin significantly reduced muscle spasms and twitching, as confirmed by electrodiagnostic studies. Similarly, patients with hemifacial spasm experienced rapid and clear improvement in symptoms with gabapentin doses ranging from 900 to 1,600 mg daily, without notable adverse effects.
Gabapentin for Muscle Pain
While gabapentin is effective for neuropathic pain and cutaneous pain, its efficacy for muscle pain is less clear. A study on healthy volunteers found that gabapentin reduced sensitivity to electrical induction of skin pain and secondary hyperalgesia but did not significantly affect muscle pain induced by hypertonic saline infusion. This suggests that while gabapentin is beneficial for certain types of pain, its effectiveness for muscle pain may be limited.
Conclusion
Gabapentin has demonstrated significant efficacy in reducing spasticity and muscle spasms in various conditions, including multiple sclerosis, spinal cord injury, and upper motor neuron syndrome. It has also shown promise in treating muscle spasms associated with Isaacs' syndrome and hemifacial spasm. However, its effectiveness for muscle pain remains inconclusive. Overall, gabapentin appears to be a valuable option for managing spasticity and muscle spasms, with a favorable safety profile.
Sources and full results
Most relevant research papers on this topic